Oral and gut microbial profiling in periodontitis and Parkinson's disease/Experiment 2

From BugSigDB


Reviewed Marked as Reviewed by Svetlana up on 2024-11-20

Curated date: 2024/11/01

Curator: Aleru Divine

Revision editor(s): Aleru Divine

Subjects

Location of subjects
Turkey
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Saliva Sailva normalis,Saliva atomaris,Saliva molecularis,Salivary gland secretion,Saliva,saliva
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Periodontitis chronic pericementitis,inflammation of periodontium,Pericementitides,Pericementitis,Periodontitides,periodontitis,Periodontitis (disorder),Periodontitis, NOS,periodontium inflammation,periodontosis,Periodontitis
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Healthy controls (HC)
Group 1 name Corresponds to the case (exposed) group for case-control studies
Parkinson's disease + Periodontitis group (PA + P)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Participants in this group had Parkinson's disease and were also diagnosed with Stage III, Grade B periodontitis.
Group 0 sample size Number of subjects in the control (unexposed) group
17
Group 1 sample size Number of subjects in the case (exposed) group
16
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
3 months

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V1-V3
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
centered log-ratio
Statistical test
ANCOM
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
No

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
increased
Simpson Estimator of species richness and species evenness: more weight on species evenness
increased
Richness Number of species
increased

Signature 1

Reviewed Marked as Reviewed by Svetlana up on 2024-11-20

Curated date: 2024/11/02

Curator: Aleru Divine

Revision editor(s): Aleru Divine

Source: Figure 4 and Figure 6

Description: Differential abundance in the oral microbiome profiles of the healthy control, Parkinson’s and non-Parkinson’s groups.

Abundance in Group 1: increased abundance in Parkinson's disease + Periodontitis group (PA + P)

NCBI Quality ControlLinks
Parvimonas micra
Prevotellaceae bacterium
Neisseria sp.
Metamycoplasma faucium
Tannerella forsythia
TM7 phylum sp. oral taxon 346
TM7 phylum sp. oral taxon 349
TM7 phylum sp. oral taxon 355
TM7 phylum sp. oral taxon 356

Revision editor(s): Aleru Divine

Signature 2

Reviewed Marked as Reviewed by Svetlana up on 2024-11-20

Curated date: 2024/11/02

Curator: Aleru Divine

Revision editor(s): Aleru Divine

Source: Figure 4 and Figure 6

Description: Differential abundance in the oral microbiome profiles of the healthy control, Parkinson’s and non-Parkinson’s groups.

Abundance in Group 1: decreased abundance in Parkinson's disease + Periodontitis group (PA + P)

NCBI Quality ControlLinks
Rothia dentocariosa
Prevotella pallens
Gemella sanguinis
Prevotella melaninogenica

Revision editor(s): Aleru Divine